The	O
CD9	B:C1701084
,	O
CD81	O
,	O
and	O
CD151	O
EC2	O
domains	I:C1517050
bind	O
to	O
the	O
classical	O
RGD	O
-	O
binding	O
site	O
of	O
integrin	O
αvβ3	I:C1138427
.	O

The	O
CD9	O
,	O
CD81	B:C1452163
,	O
and	O
CD151	O
EC2	O
domains	I:C1517050
bind	O
to	O
the	O
classical	O
RGD	O
-	O
binding	O
site	O
of	O
integrin	O
αvβ3	I:C1138427
.	O

The	O
CD9	O
,	O
CD81	O
,	O
and	O
CD151	B:C0389372
EC2	O
domains	I:C1517050
bind	O
to	O
the	O
classical	O
RGD	O
-	O
binding	O
site	O
of	O
integrin	O
αvβ3	I:C1138427
.	O

The	O
CD9	O
,	O
CD81	O
,	O
and	O
CD151	O
EC2	B:C1517050
domains	I:C1517050
bind	O
to	O
the	O
classical	O
RGD	O
-	O
binding	O
site	O
of	O
integrin	O
αvβ3	I:C1138427
.	O

The	O
CD9	O
,	O
CD81	O
,	O
and	O
CD151	O
EC2	O
domains	I:C1517050
bind	B:C1167622
to	O
the	O
classical	O
RGD	O
-	O
binding	O
site	O
of	O
integrin	O
αvβ3	I:C1138427
.	O

The	O
CD9	O
,	O
CD81	O
,	O
and	O
CD151	O
EC2	O
domains	I:C1517050
bind	O
to	O
the	O
classical	O
RGD	O
-	O
binding	O
site	O
of	O
integrin	B:C1138427
αvβ3	I:C1138427
.	O

Tetraspanins	B:C3178812
play	O
important	O
roles	O
in	O
normal	O
(	O
e.g.	O
,	O
cell	O
adhesion	I:C0007577
,	O
motility	O
,	O
activation	O
,	O
and	O
proliferation	O
)	O
,	O
and	O
pathological	O
conditions	O
(	O
e.g.	O
,	O
metastasis	O
and	O
viral	O
infection	I:C0042769
)	O
.	O

Tetraspanins	O
play	O
important	O
roles	O
in	O
normal	O
(	O
e.g.	O
,	O
cell	B:C0007577
adhesion	I:C0007577
,	O
motility	O
,	O
activation	O
,	O
and	O
proliferation	O
)	O
,	O
and	O
pathological	O
conditions	O
(	O
e.g.	O
,	O
metastasis	O
and	O
viral	O
infection	I:C0042769
)	O
.	O

Tetraspanins	O
play	O
important	O
roles	O
in	O
normal	O
(	O
e.g.	O
,	O
cell	O
adhesion	I:C0007577
,	O
motility	B:C0007608
,	O
activation	O
,	O
and	O
proliferation	O
)	O
,	O
and	O
pathological	O
conditions	O
(	O
e.g.	O
,	O
metastasis	O
and	O
viral	O
infection	I:C0042769
)	O
.	O

Tetraspanins	O
play	O
important	O
roles	O
in	O
normal	O
(	O
e.g.	O
,	O
cell	O
adhesion	I:C0007577
,	O
motility	O
,	O
activation	B:C1326120
,	O
and	O
proliferation	O
)	O
,	O
and	O
pathological	O
conditions	O
(	O
e.g.	O
,	O
metastasis	O
and	O
viral	O
infection	I:C0042769
)	O
.	O

Tetraspanins	O
play	O
important	O
roles	O
in	O
normal	O
(	O
e.g.	O
,	O
cell	O
adhesion	I:C0007577
,	O
motility	O
,	O
activation	O
,	O
and	O
proliferation	B:C0596290
)	O
,	O
and	O
pathological	O
conditions	O
(	O
e.g.	O
,	O
metastasis	O
and	O
viral	O
infection	I:C0042769
)	O
.	O

Tetraspanins	O
play	O
important	O
roles	O
in	O
normal	O
(	O
e.g.	O
,	O
cell	O
adhesion	I:C0007577
,	O
motility	O
,	O
activation	O
,	O
and	O
proliferation	O
)	O
,	O
and	O
pathological	O
conditions	O
(	O
e.g.	O
,	O
metastasis	B:C4255448
and	O
viral	O
infection	I:C0042769
)	O
.	O

Tetraspanins	O
play	O
important	O
roles	O
in	O
normal	O
(	O
e.g.	O
,	O
cell	O
adhesion	I:C0007577
,	O
motility	O
,	O
activation	O
,	O
and	O
proliferation	O
)	O
,	O
and	O
pathological	O
conditions	O
(	O
e.g.	O
,	O
metastasis	O
and	O
viral	B:C0042769
infection	I:C0042769
)	O
.	O

Tetraspanins	B:C3178812
interact	O
with	O
integrins	O
and	O
regulate	O
integrin	O
functions	O
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	O
-	O
integrin	O
interaction	O
are	O
unclear	O
.	O

Tetraspanins	O
interact	B:C0007582
with	O
integrins	O
and	O
regulate	O
integrin	O
functions	O
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	O
-	O
integrin	O
interaction	O
are	O
unclear	O
.	O

Tetraspanins	O
interact	O
with	O
integrins	B:C0021701
and	O
regulate	O
integrin	O
functions	O
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	O
-	O
integrin	O
interaction	O
are	O
unclear	O
.	O

Tetraspanins	O
interact	O
with	O
integrins	O
and	O
regulate	O
integrin	B:C0021701
functions	O
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	O
-	O
integrin	O
interaction	O
are	O
unclear	O
.	O

Tetraspanins	O
interact	O
with	O
integrins	O
and	O
regulate	O
integrin	O
functions	B:C1148560
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	O
-	O
integrin	O
interaction	O
are	O
unclear	O
.	O

Tetraspanins	O
interact	O
with	O
integrins	O
and	O
regulate	O
integrin	O
functions	O
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	B:C3178812
-	O
integrin	O
interaction	O
are	O
unclear	O
.	O

Tetraspanins	O
interact	O
with	O
integrins	O
and	O
regulate	O
integrin	O
functions	O
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	O
-	O
integrin	B:C0021701
interaction	O
are	O
unclear	O
.	O

Tetraspanins	O
interact	O
with	O
integrins	O
and	O
regulate	O
integrin	O
functions	O
,	O
but	O
the	O
specifics	O
of	O
tetraspanin	O
-	O
integrin	O
interaction	B:C0007582
are	O
unclear	O
.	O

Using	O
co-immunoprecipitation	B:C1449705
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	B:C0021701
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	B:C0007582
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	B:C0021701
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	B:C3178812
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	B:C1517050
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	B:C1517050
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	B:C3178812
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	B:C0005456
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	O
.	O

Using	O
co-immunoprecipitation	O
with	O
integrins	O
as	O
a	O
sole	O
method	O
to	O
detect	O
interaction	O
between	O
integrins	O
and	O
full	O
-	O
length	O
tetraspanins	O
,	O
it	O
has	O
been	O
proposed	O
that	O
the	O
variable	O
region	O
(	O
helices	O
D	O
and	O
E	O
)	O
of	O
the	O
extracellular	O
-	I:C1517050
2	I:C1517050
(	O
extracellular	O
-	I:C1517050
2	I:C1517050
)	O
of	O
tetraspanins	O
laterally	O
associate	O
with	O
non-ligand	O
-	I:C0005456
binding	I:C0005456
site	I:C0005456
of	O
integrins	B:C0021701
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	B:C0007577
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	B:C0005507
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	B:C1517050
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	B:C1452163
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	B:C1701084
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	B:C0389372
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	B:C1138427
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	B:C1167622
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	B:C0762960
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	B:C0003139
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	B:C1138427
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	B:C0288672
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	B:C0682969
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	O
3	I:C0245726
.	O

We	O
describe	O
that	O
,	O
using	O
adhesion	O
assays	O
,	O
the	O
EC2	O
domain	I:C1517050
of	O
CD81	O
,	O
CD9	O
,	O
and	O
CD151	O
bound	O
to	O
integrin	O
αvβ3	I:C1138427
and	O
this	O
binding	O
was	O
suppressed	O
by	O
cRGDfV	O
,	O
a	O
specific	O
inhibitor	O
of	O
αvβ3	O
,	O
and	O
antibody	O
7E3	I:C0288672
that	O
is	O
mapped	O
to	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
β	B:C0245726
3	I:C0245726
.	O

We	O
also	O
present	O
evidence	O
that	O
the	O
specificity	O
loop	B:C0445022
of	O
β	O
3	I:C0245726
directly	O
bound	O
to	O
the	O
EC2	O
domains	I:C1517050
.	O

We	O
also	O
present	O
evidence	O
that	O
the	O
specificity	O
loop	O
of	O
β	B:C0245726
3	I:C0245726
directly	O
bound	O
to	O
the	O
EC2	O
domains	I:C1517050
.	O

We	O
also	O
present	O
evidence	O
that	O
the	O
specificity	O
loop	O
of	O
β	O
3	I:C0245726
directly	O
bound	B:C1167622
to	O
the	O
EC2	O
domains	I:C1517050
.	O

We	O
also	O
present	O
evidence	O
that	O
the	O
specificity	O
loop	O
of	O
β	O
3	I:C0245726
directly	O
bound	O
to	O
the	O
EC2	B:C1517050
domains	I:C1517050
.	O

This	O
suggests	O
that	O
the	O
EC2	B:C1517050
domains	I:C1517050
specifically	O
binds	O
to	O
the	O
classical	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
αvβ3	O
.	O

This	O
suggests	O
that	O
the	O
EC2	O
domains	I:C1517050
specifically	O
binds	B:C1167622
to	O
the	O
classical	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
αvβ3	O
.	O

This	O
suggests	O
that	O
the	O
EC2	O
domains	I:C1517050
specifically	O
binds	O
to	O
the	O
classical	O
ligand	B:C0682969
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
αvβ3	O
.	O

This	O
suggests	O
that	O
the	O
EC2	O
domains	I:C1517050
specifically	O
binds	O
to	O
the	O
classical	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
αvβ3	B:C1138427
.	O

αvβ3	B:C1138427
was	O
a	O
more	O
effective	O
receptor	O
for	O
the	O
EC2	O
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	O
receptors	O
α3	O
β1	I:C0246766
,	O
α4β1	O
,	O
and	O
α6β1	O
.	O

αvβ3	O
was	O
a	O
more	O
effective	O
receptor	B:C0597357
for	O
the	O
EC2	O
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	O
receptors	O
α3	O
β1	I:C0246766
,	O
α4β1	O
,	O
and	O
α6β1	O
.	O

αvβ3	O
was	O
a	O
more	O
effective	O
receptor	O
for	O
the	O
EC2	B:C1517050
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	O
receptors	O
α3	O
β1	I:C0246766
,	O
α4β1	O
,	O
and	O
α6β1	O
.	O

αvβ3	O
was	O
a	O
more	O
effective	O
receptor	O
for	O
the	O
EC2	O
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	B:C3178812
receptors	O
α3	O
β1	I:C0246766
,	O
α4β1	O
,	O
and	O
α6β1	O
.	O

αvβ3	O
was	O
a	O
more	O
effective	O
receptor	O
for	O
the	O
EC2	O
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	O
receptors	B:C0597357
α3	O
β1	I:C0246766
,	O
α4β1	O
,	O
and	O
α6β1	O
.	O

αvβ3	O
was	O
a	O
more	O
effective	O
receptor	O
for	O
the	O
EC2	O
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	O
receptors	O
α3	B:C0246766
β1	I:C0246766
,	O
α4β1	O
,	O
and	O
α6β1	O
.	O

αvβ3	O
was	O
a	O
more	O
effective	O
receptor	O
for	O
the	O
EC2	O
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	O
receptors	O
α3	O
β1	I:C0246766
,	O
α4β1	B:C0209606
,	O
and	O
α6β1	O
.	O

αvβ3	O
was	O
a	O
more	O
effective	O
receptor	O
for	O
the	O
EC2	O
domains	I:C1517050
than	O
previously	O
known	O
tetraspanin	O
receptors	O
α3	O
β1	I:C0246766
,	O
α4β1	O
,	O
and	O
α6β1	B:C0246951
.	O

Docking	B:C3494273
simulation	I:C3494273
predicted	O
that	O
the	O
helices	O
A	O
and	O
B	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
binds	O
to	O
the	O
RGD	O
-	O
binding	O
site	O
of	O
αvβ3	O
.	O

Docking	O
simulation	I:C3494273
predicted	O
that	O
the	O
helices	O
A	O
and	O
B	O
of	O
CD81	B:C1452163
extracellular	O
-	I:C1517050
2	I:C1517050
binds	O
to	O
the	O
RGD	O
-	O
binding	O
site	O
of	O
αvβ3	O
.	O

Docking	O
simulation	I:C3494273
predicted	O
that	O
the	O
helices	O
A	O
and	O
B	O
of	O
CD81	O
extracellular	B:C1517050
-	I:C1517050
2	I:C1517050
binds	O
to	O
the	O
RGD	O
-	O
binding	O
site	O
of	O
αvβ3	O
.	O

Docking	O
simulation	I:C3494273
predicted	O
that	O
the	O
helices	O
A	O
and	O
B	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
binds	B:C1167622
to	O
the	O
RGD	O
-	O
binding	O
site	O
of	O
αvβ3	O
.	O

Docking	O
simulation	I:C3494273
predicted	O
that	O
the	O
helices	O
A	O
and	O
B	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
binds	O
to	O
the	O
RGD	O
-	O
binding	O
site	O
of	O
αvβ3	B:C1138427
.	O

Substituting	O
Lys	B:C0024337
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	B:C0733755
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	B:C1452163
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	B:C1517050
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	B:C0021701
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	B:C1167622
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	B:C1167622
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	B:C1452163
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	B:C1517050
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	B:C1138427
,	O
consistent	O
with	O
the	O
docking	O
model	I:C3494273
.	O

Substituting	O
Lys	O
residues	I:C0024337
at	O
position	O
116	O
,	O
144/148	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
in	O
the	O
predicted	O
integrin	O
-	O
binding	O
interface	O
reduced	O
the	O
binding	O
of	O
CD81	O
extracellular	O
-	I:C1517050
2	I:C1517050
to	O
αvβ3	O
,	O
consistent	O
with	O
the	O
docking	B:C3494273
model	I:C3494273
.	O

These	O
findings	B:C0243095
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	O
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	B:C3641828
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	O
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	B:C0026344
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	O
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	B:C0682969
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	O
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	B:C1138427
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	O
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	B:C3178812
receptor	O
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	B:C0597357
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	O
,	O
binds	B:C1167622
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	O
domain	I:C1517050
.	O

These	O
findings	O
suggest	O
that	O
,	O
in	O
contrast	I:C3641828
to	O
previous	O
models	O
,	O
the	O
ligand	O
-	I:C0682969
binding	I:C0682969
site	I:C0682969
of	O
integrin	O
αvβ3	I:C1138427
,	O
a	O
new	O
tetraspanin	O
receptor	O
,	O
binds	O
to	O
the	O
constant	O
region	O
(	O
helices	O
A	O
and	O
B	O
)	O
of	O
the	O
EC2	B:C1517050
domain	I:C1517050
.	O

